Ensign Peak Advisors
CNCE

Ensign Peak Advisors’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Ensign Peak Advisors’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
2022
Q4 		$516K Hold
2022
Q3 		$592K Hold
2022
Q2 		$372K Buy
2021
Q1 		– Sell
2020
Q4 		$493K Buy